Monitoring Gene Expression in Retina with Synthetic Serum Markers
Lu, J.; Lee, S.; Wang, M.; Zheng, K.; Oh, S. H.; Lee, J.; Soh, S.; Cao, Y.; Bao, X.; Huang, Y.; Nouraein, S.; Wu, Z.; Szablowski, J. O.; Chen, R.
Show abstract
Gene expression underlies retinal development, function, and pathogenesis. However, monitoring retinal gene expression in vivo is challenging. In this study, we apply synthetic serum markers, called Released Markers of Activity, or RMAs, to quantify gene expression in an intact retina through a simple blood test. We show that RMAs can quantify transduction of multiple retinal cell-types and monitor cell implantation or cell loss. We found RMAs are sensitive enough to measure transduction of rare cell populations, such as retinal ganglion cells and could detect transplantation of as few as 100 stem cells. Expression of RMAs showed no evidence of cell loss or immune activation in the retina. Overall, these findings demonstrate that RMAs are highly sensitive, tissue non-destructive gene expression reporters that can continuously track gene delivery and cell survival in intact retina through a simple blood test.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A novel multiplex RNAi therapy simultaneously targets Hif1a and Hif2a to defy retinal degeneration in two models of AMD 97%
- AAV NRF2 Gene Therapy Preserves Retinal Structure and Function in Rodent Models of Oxidative Damage 96%
- Dual CRALBP isoforms unveiled: iPSC-derived retinal modelling and AAV2/5-RLBP1 gene transfer raise considerations for effective therapy 95%
Similar papers in this journal
- Optimizing AAV2/6 microglial targeting identified enhanced efficiency in the photoreceptor degenerative environment 97%
- Outcomes of Progranulin Gene Therapy in the Retina are Dependent on Time of Delivery 96%
- Systemic and local immune response to intraocular AAV vector administration in non-human primates 95%
Similar papers in this journal
Similar papers in this journal
- Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration 95%
- Late gene therapy limits the restoration of retinal function in a mouse model of retinitis pigmentosa 95%
- Restoration of visual function by transplantation of optogenetically engineered photoreceptors 94%
Similar papers in this journal
- Introduced chemokine gradients guide transplanted and regenerated retinal neurons toward their natural position in the retina 96%
- RPE-specific MCT2 expression promotes cone survival in models of retinitis pigmentosa 95%
- Targeting ON-bipolar cells by AAV gene therapy stably reverses LRIT3-congenital stationary night blindness 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.